Quick Takeaways
- Thomas G. Wiggans has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $113,830.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Thomas G. Wiggans
- Location
- Palo Alto, CA
- Summary
- The estimated net worth of Thomas G. Wiggans is at least $113,830 dollars as of 24 Sep 2025. Thomas G. Wiggans is the Director of Jasper Therapeutics, Inc. and owns shares of Jasper Therapeutics, Inc. (JSPR) stock worth about $113.8K.
- Signature
- /s/ Herb Cross, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Thomas G. Wiggans and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Jasper Therapeutics, Inc. ($113,830).
- Past-year value change for that position: +$99,630.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Thomas G. Wiggans
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| JSPR, JSPRW | Jasper Therapeutics, Inc. | Director | $113,830 | +$99,630 | +702% | 22 Sep 2025 |
| ANNX | Annexon, Inc. | Director | 05 Jun 2025 | |||
| CBAY | CymaBay Therapeutics, Inc. | Director | 22 Mar 2024 | |||
| FMTX | Forma Therapeutics Holdings, Inc. | Director | 14 Oct 2022 | |||
| PRDS | PARDES BIOSCIENCES, INC. | Chief Executive Officer, Director | 31 Aug 2023 |
Insider Transactions Reported by Thomas G. Wiggans:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.